<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gomez de Las Heras MM</submitter><funding>European Research Council</funding><pagination>eadv0985</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7618201</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(110)</volume><pubmed_abstract>Healthy aging relies on a symbiotic host-microbiota relationship. The age-associated decline of the immune system can pose a threat to this delicate equilibrium. In this work, we investigated how the functional deterioration of T cells can affect host-microbiota symbiosis and gut barrier integrity and the implications of this deterioration for inflammaging, senescence, and health decline. Using the &lt;i>Tfam&lt;/i>&lt;sup>fl/fl&lt;/sup>&lt;i>Cd4&lt;/i>&lt;sup>Cre&lt;/sup> mouse model, we found that T cell failure compromised gut immunity leading to a decrease in T follicular cells and regulatory T cells (T&lt;sub>reg&lt;/sub> cells) and an accumulation of highly proinflammatory and cytotoxic T cells. These alterations were associated with intestinal barrier disruption and gut dysbiosis. Microbiota depletion or adoptive transfer of total CD4 T cells or a T&lt;sub>reg&lt;/sub> cell-enriched pool prevented gut barrier dysfunction and mitigated premature inflammaging and senescence, ultimately enhancing the health span in this mouse model. Thus, a competent CD4 T cell compartment is critical to ensure healthier aging by promoting host-microbiota mutualism and gut barrier integrity.</pubmed_abstract><journal>Science immunology</journal><pubmed_title>CD4 T cell therapy counteracts inflammaging and senescence by preserving gut barrier integrity.</pubmed_title><pmcid>PMC7618201</pmcid><funding_grant_id>101044248</funding_grant_id><pubmed_authors>Fernandez-Almeida A</pubmed_authors><pubmed_authors>Francos-Quijorna I</pubmed_authors><pubmed_authors>Aranda JF</pubmed_authors><pubmed_authors>Dias-Almeida J</pubmed_authors><pubmed_authors>Simo C</pubmed_authors><pubmed_authors>Nunez G</pubmed_authors><pubmed_authors>Delgado-Pulido S</pubmed_authors><pubmed_authors>Galvez-Castano MI</pubmed_authors><pubmed_authors>Gomez de Las Heras MM</pubmed_authors><pubmed_authors>Mittelbrunn M</pubmed_authors><pubmed_authors>Garcia-Canas V</pubmed_authors><pubmed_authors>Escrig-Larena JI</pubmed_authors><pubmed_authors>Perez-Manrique M</pubmed_authors><pubmed_authors>Soto-Heredero G</pubmed_authors><pubmed_authors>Gabande-Rodriguez E</pubmed_authors><pubmed_authors>Inohara N</pubmed_authors><pubmed_authors>Carrasco E</pubmed_authors><pubmed_authors>Blanco EM</pubmed_authors></additional><is_claimable>false</is_claimable><name>CD4 T cell therapy counteracts inflammaging and senescence by preserving gut barrier integrity.</name><description>Healthy aging relies on a symbiotic host-microbiota relationship. The age-associated decline of the immune system can pose a threat to this delicate equilibrium. In this work, we investigated how the functional deterioration of T cells can affect host-microbiota symbiosis and gut barrier integrity and the implications of this deterioration for inflammaging, senescence, and health decline. Using the &lt;i>Tfam&lt;/i>&lt;sup>fl/fl&lt;/sup>&lt;i>Cd4&lt;/i>&lt;sup>Cre&lt;/sup> mouse model, we found that T cell failure compromised gut immunity leading to a decrease in T follicular cells and regulatory T cells (T&lt;sub>reg&lt;/sub> cells) and an accumulation of highly proinflammatory and cytotoxic T cells. These alterations were associated with intestinal barrier disruption and gut dysbiosis. Microbiota depletion or adoptive transfer of total CD4 T cells or a T&lt;sub>reg&lt;/sub> cell-enriched pool prevented gut barrier dysfunction and mitigated premature inflammaging and senescence, ultimately enhancing the health span in this mouse model. Thus, a competent CD4 T cell compartment is critical to ensure healthier aging by promoting host-microbiota mutualism and gut barrier integrity.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-06-04T04:49:23.278Z</modification><creation>2026-05-05T03:12:38.102Z</creation></dates><accession>S-EPMC7618201</accession><cross_references><pubmed>40749035</pubmed><doi>10.1126/sciimmunol.adv0985</doi></cross_references></HashMap>